A current article referred to the importance of an adequate diagnosis as soon as possible, preferably at birth (medscape.com).
Furthermore, the author summarized that therapeutic approaches are targeted on the production of SMN protein. Due to the fact, that affected motoneurons are irreversibly damaged, an early therapy is essential.
Source: medscape.com, January 2018, Author: Dr. Jürgen Sartorius